Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vet groups issue Brucella canis advice for practices
The organisations say that the serological test results should be interpreted with other evidence.
Government urged to take action on imported Brucella canis cases.

Major veterinary organisations have launched a joint policy for practices, advising them on how to manage Brucella canis cases.

The policy comes as they call on the UK government to tighten pet import restrictions to control the spread of the disease.

The British Veterinary Association (BVA), the British Small Animal Veterinary Association (BSAVA), Society for Practising Veterinary Surgeons (SPVS) and British Veterinary Nursing Association (BVNA) have collaborated to release 13 recommendations for the diagnosis, testing and management of Brucella canis.

The joint policy position recommends that veterinary surgeons use their clinical judgement, as well as information from BSAVA and APHA, to make contextualised decisions when testing for Brucella canis. These decisions should also consider a risk assessment, as well as conversations with the animal owner and other stakeholders.

This includes making the owners aware of the costs and potential outcome before the tests are conducted, ensuring informed consent is received.

Veterinary practices can use SAT and iELISA serological tests to assess if a dog is infected with Brucella canis. The tests should use blood samples that have been taken three months after a potential infection.

However the groups say that the results should be interpreted with other evidence, including clinical signs, likelihood of exposure and movement history.

They advise veterinary practices to consider all clinical information alongside laboratory results, and to assess each case of Brucella canis individually when deciding on treatment or euthanasia options. The impact of the disease on the dog and those around it should take priority over its lifespan.

The group have emphasised the importance of raising awareness of clinical signs and risk factors, among colleagues and the public, to better manage the disease.

Data from the UK government showed that cases have risen from just three before 2020, to 240 cases in the past three years. In 2022 the first UK case of dog-to-human transmission was reported, revealing a relatively low risk to those handling infected dogs.

The veterinary organisations have appealed to the UK government to introduce appropriate pre-import testing for B. canis. They are also calling on the government to tighten the movement of dogs from countries with high rates of the disease.

BVA president Anna Judson: “The rise in detected cases of Brucella canis in recent years must be taken seriously, while keeping in mind that that the risk to humans, even for veterinary teams, is deemed to be low at present.

“Testing and decision-making for suspected or confirmed B. canis cases can be complicated and challenging, which is why our advice to veterinary professionals is to make use of the risk assessment information provided by APHA, BSAVA and BVA when making any decision.”

The full advice can be found here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.